These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27074737)

  • 21. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study.
    Wakugawa Y; Kiyohara Y; Tanizaki Y; Kubo M; Ninomiya T; Hata J; Doi Y; Okubo K; Oishi Y; Shikata K; Yonemoto K; Maebuchi D; Ibayashi S; Iida M
    Stroke; 2006 Jan; 37(1):27-32. PubMed ID: 16306468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between self-rated health and high-sensitivity C-reactive protein level: a cross-sectional and 5-year longitudinal study.
    Tamura T; Naito M; Maruyama K; Tsukamoto M; Sasakabe T; Okada R; Kawai S; Hishida A; Wakai K
    BMC Public Health; 2018 Dec; 18(1):1380. PubMed ID: 30558565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study.
    Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Yoshimasa Y; Okayama A
    Atherosclerosis; 2010 Mar; 209(1):290-4. PubMed ID: 19801148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction.
    Al Aseri ZA; Habib SS; Marzouk A
    Vasc Health Risk Manag; 2019; 15():221-227. PubMed ID: 31410012
    [No Abstract]   [Full Text] [Related]  

  • 27. The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study.
    Fujii M; Ohnishi H; Saitoh S; Akasaka H; Miura T; Mori M
    Hypertens Res; 2015 Jun; 38(6):426-32. PubMed ID: 25787035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of high sensitivity C-reactive protein level for predicting risk of nonalcoholic fatty liver in type 2 diabetes mellitus patients].
    Jiang XZ; Wang JJ; Wu SL; Zhang YM; Zhang J; Wang JL; Duan HL; Li GJ; Wang Q
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):57-61. PubMed ID: 23663765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway.
    Laugsand LE; Åsvold BO; Vatten LJ; Janszky I; Platou C; Michelsen AE; Arain F; Damås JK; Aukrust P; Ueland T
    Atherosclerosis; 2016 Jan; 244():188-94. PubMed ID: 26649903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study.
    Cristell N; Cianflone D; Durante A; Ammirati E; Vanuzzo D; Banfi M; Calori G; Latib A; Crea F; Marenzi G; De Metrio M; Moretti L; Li H; Uren NG; Hu D; Maseri A;
    J Am Coll Cardiol; 2011 Dec; 58(25):2654-61. PubMed ID: 22152952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men.
    Tomiyama H; Arai T; Koji Y; Yambe M; Hirayama Y; Yamamoto Y; Yamashina A
    Atherosclerosis; 2004 Jun; 174(2):373-7. PubMed ID: 15136069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
    Eltoft A; Arntzen KA; Wilsgaard T; Hansen JB; Mathiesen EB; Johnsen SH
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association between baseline high sensitivity C-reactive protein level and the first cardio-cerebral vascular event in diabetic population: a prospective cohort study].
    Wang LY; Wu SL; Yang XL; Wang TJ; Su LR; Gao JS; Zheng XM; Liu XR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):749-54. PubMed ID: 22169424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
    Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse relationship between serum hsCRP concentration and hand grip strength in older adults: a nationwide population-based study.
    Kim BJ; Lee SH; Kwak MK; Isales CM; Koh JM; Hamrick MW
    Aging (Albany NY); 2018 Aug; 10(8):2051-2061. PubMed ID: 30115813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between circulating endostatin levels and incident myocardial infarction.
    Ruge T; Carlsson AC; Jansson JH; Söderberg S; Larsson A; Ärnlöv J
    Scand Cardiovasc J; 2018 Dec; 52(6):315-319. PubMed ID: 30474426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.